DTx in Medical – Thematic Intelligence
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Reasons to buy the ‘DTx in Medical’ thematic intelligence report:
- Identify the companies most likely to succeed in a world filled with disruptive threats.
- Predict how each theme will evolve and identify the leading and disrupting companies.
- Get an overview of the digital therapeutics theme.
- Analyze the emerging technological, macroeconomic, and regulatory trends shaping the DTx in medical theme and understand their broader impact on the market.
How is our ‘DTx in Medical’ report unique from other reports in the market?
- Develop and design your corporate strategies through an in-house expert analysis of digital therapeutics.
- Understand the primary ways in which this theme is impacting the healthcare industry.
- Stay up to date on the industry’s major players and where they sit in the value chain.
- Identify emerging industry trends to gain a competitive advantage.
We recommend this valuable source of information to anyone involved in:
- Medical Device Companies
- Health Tech Companies
- Tech Startups and Leaders
- Researchers and Academics
- Consulting Firms/Investing Firms
- Venture Capital/Equity Firms
To Get a Snapshot of the DTx in Medical Thematic Report
DTX in Medical Thematic Report Overview
Digital therapeutics (DTx) are software-based interventions that deliver evidence-based therapeutic interventions to patients. The interventions are driven by high-quality software programs to prevent, manage, or treat a medical condition. The majority of DTx are designed to treat chronic, respiratory, and mental health or neurological conditions. The use of DTx generally requires a prescription, as the interventions must be cleared or certified by regulatory bodies to support their claims.
The DTx in medical thematic intelligence report is a thematic brief, which identifies companies most likely to succeed in a world filled with disruptive threats. In the report, we predict how each theme will evolve and identify the leading and disrupting companies.
Report Pages | 38 |
Regions Covered | Global |
Key Value Chain Components | · DTx Markets
· Services · Experience |
Key Trends | · Technology Trends
· Macroeconomic Trends · Regulatory Trends |
Leading Public Companies | · Adherium
· AstraZeneca · Better Therapeutics · DarioHealth · ResMed · Teladoc Health |
Leading Private Companies | · Amiko Digital Health
· Big Health · Biofourmis · CureApp · Kaia Health · Sword Health · Twill · Voluntis |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
DTx in Medical – Key Trends
The primary trends that will shape the DTx theme over the next 12-24 months are classified into technology trends, macroeconomic trends, and regulatory trends.
- Technology trends: The key technology trends impacting the DTx theme are the implementation of AI, the use of remote-patient monitoring, and wearable technology, among others.
- Macroeconomic trends: Increasing healthcare costs, an aging population, and public health emergencies among others are macroeconomic trends expected to drive the DTx market in the coming years.
- Regulatory trends: The rise in software as a medical device regulation is a key regulatory trend impacting the DTx market. For instance, In Europe, the new Medical Device Regulation and In Vitro Diagnostic Device Regulation include a medical device software (MDSW) consideration. A software digital health app will qualify as a “medical device” if it is intended to be used for one or more of the medical purposes specified in the definition of a medical device or in vitro diagnostic, which includes the diagnosis, treatment, and monitoring of a disease, injury, or disability.
DTx in Medical – Industry Analysis
There are 733 DTx pipeline products, and nervous system conditions are the most common therapy area for DTx products. Indications associated with nervous system diseases include chronic pain, generalized anxiety disorder, social anxiety disorder, major depressive disorder, alcohol use disorder, ADHD, and speech disorder.
A majority of the devices in the pipeline products database are expected to be approved during 2024-2027, however, a few are also expected to be approved in 2028 and 2029
The in DTx analysis also covers:
- Timeline
- Signals
- M&A trends
- Venture financing trends
- Patent trends
- Company filing trends
DTx Pipeline Products By Therapy Area
Buy the Full Report for More Insights into the DTx Theme in the Medical Market
DTx in Medical - Value Chain Analysis
The DTx value chain can be split into the DTx markets, services, and experience.
DTx Markets: DTx markets is further segmented into chronic conditions, respiratory conditions, and mental health and neurological conditions.
Chronic conditions are long-term health issues that persist over an extended period of time and require ongoing medical attention. The symptoms of chronic conditions can range from relatively mild to severe, and they can have an impact on a patient’s life, including physical and mental health, daily functioning, and overall quality of life.
Power Industry Value Chain Analysis
Buy the Full Report for More Insights into the DTx Value Chain
DTx– Competitive Landscape
A few leading DTx public companies making their mark within the DTx theme are:
- Adherium
- AstraZeneca
- Better Therapeutics
- DarioHealth
Adherium is a digital health company that offers smart devices to treat patients suffering from respiratory conditions such as asthma and COPD. Adherium’s DTx solution, Hailie, enables patients to control their respiratory conditions by tracking medication usage and obtaining alerts on timely medication intake.
A few leading DTx private companies making their mark within the DTx theme are:
- Amiko Digital Health
- Big Health
- Biofourmis
Amiko Digital Health is a developer of AI digital health tools and medication sensor technologies used by healthcare providers. Amiko’s first product is Respiro, a digital medicine product that uses sensors built into inhalers to record usage and measure inhalation flow.
Buy the Full Report to Know More About the Leading Companies in the DTx Market
Medical Devices Sector Scorecard
At GlobalData, we use a scorecard approach to predict tomorrow’s leading companies within each sector. Our power sector scorecard has three screens: a thematic screen, a valuation screen, and a risk screen.
- The thematic screen ranks companies based on overall leadership in the 10 themes that matter most to their industry, generating a leading indicator of future performance.
- The valuation screen ranks our universe of companies within a sector based on selected valuation metrics.
- The risk screen ranks companies within a particular sector based on overall investment risk.
Medical Devices Sector Scorecard – Thematic Screen
Buy the Full Report to Know More About the Sector Scorecards
Twill
Teledoc Health
Voluntis
Sword Health
Click Therapeutics
WellDoc
Biofourmis
DarioHealth
Kaia Health
Noom
ResMed
Adherium
Pulmonx
AstraZeneca
Akili Interactive
Big Health
Table of Contents
Frequently asked questions
-
What are the key trends impacting the DTx theme in the medical market?
The primary trends that will shape the DTx over the next 12 to 24 months are classified into technology trends, macroeconomic trends, and regulatory trends.
-
What are the key components of the DTx in the medical value chain?
The DTx value chain can be split into the DTx markets, services, and experience.
-
Which are the leading private companies making their mark within the DTx theme?
A few of the leading companies making their mark within the DTx theme are Amiko Digital, Health, Big Health, and Biofourmis.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.